Awakn Life Sciences Completes World’s First Ketamine Treatment Study for a Range of Behavioral Addictions May 19, 2022
Awakn Life Sciences Provides Shareholder Update on Three Operational Ketamine-Assisted Therapy Clinics in the UK and… Apr 13, 2022
Tryp Therapeutics Submits IND Application For Phase 2a Clinical Trial In Eating Disorders Sep 22, 2021
Can Psilocybin Treat Hyperphagia? Tryp Therapeutics’ Jim Gilligan & Dr. Jennifer Miller Want To Know May 3, 2021